Monoclonal antibodies protect against pandrug-resistant Klebsiella pneumoniae

The ‘silent pandemic’ caused by antimicrobial resistance requires innovative therapeutic approaches. Human monoclonal antibodies (mAbs), which are among the most transformative and safe drugs in oncology 1 and autoimmunity 2 , are rarely used for infectious diseases and not yet used for antimicrobia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature (London) Jg. 646; H. 8087; S. 1204 - 1213
Hauptverfasser: Roscioli, Emanuele, Zucconi Galli Fonseca, Vittoria, Bosch, Soraya Soledad, Paciello, Ida, Maccari, Giuseppe, Cardinali, Giulia, Batani, Giampiero, Stazzoni, Samuele, Tiseo, Giusy, Giordano, Cesira, Yuwei, Shen, Capoccia, Laura, Cardamone, Dario, Ridelfi, Matteo, Troisi, Marco, Manganaro, Noemi, Mugnaini, Chiara, De Santi, Concetta, Ciabattini, Annalisa, Cerofolini, Linda, Fragai, Marco, Licastro, Danilo, Wyres, Kelly, Dortet, Laurent, Barnini, Simona, Nicolau, David P., Menichetti, Francesco, Falcone, Marco, Abdelraouf, Kamilia, Sala, Claudia, Kabanova, Anna, Rappuoli, Rino
Format: Journal Article
Sprache:Englisch
Veröffentlicht: London Nature Publishing Group UK 30.10.2025
Nature Publishing Group
Schlagworte:
ISSN:0028-0836, 1476-4687, 1476-4687
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!